Drug class
Recombinant tissue-type plasminogen activator (rt-PA); fibrinolytic thrombolytic agent
Mechanism of action
A serine protease that catalyses conversion of plasminogen to plasmin. Activation is enhanced in the presence of fibrin, promoting degradation of fibrin-rich thrombi.
General use cases
- Acute ischaemic stroke in appropriately selected patients within the product-specific treatment window
- Acute myocardial infarction and acute massive pulmonary embolism in selected clinical settings
- Restoration of function to central venous access devices occluded by thrombus with the low-dose catheter-lock formulation; indications and dosing are formulation-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
